Abstract
Accurate terminology is the basis for clear communication among specialists and relies upon precise definitions, indispensable for the WHO Classification of Tumours. We identified a number of potentially misleading terms in use in the recently published WHO Classification of Tumours, 5th edition. From a list of common sources that might be consulted by specialists in the pathology field, we searched for definitions of the terms. Where at least two sources provided definitions for a term, we assessed their level of agreement using an ad hoc developed scale. We identified 26 potentially misleading terms from the 5th edition Digestive System and Breast Tumour Books, and 16 sources. The number of definitions provided by the sources ranged from no definition (for four terms) to ten (for two terms). No source had definitions for all terms. We found only 111 (27%) of a possible 416 definitions. Where two or more definitions were present for a term, the level of agreement between them was judged to be high. There was a paucity of definitions for potentially misleading terms in the sources consulted, but there was a good agreement when two or more definitions were present. In a globalized world where healthcare workers and learners in many fields may access these sources to learn about terminology with which they are unfamiliar, the lack of definitions is a hindrance to a precise understanding of classification in the speciality of pathology and to clear communication between specialist groups.
Avoid common mistakes on your manuscript.
Introduction
The International Agency for Research on Cancer (IARC) is the specialized cancer research agency of the World Health Organization (WHO). A significant feature of IARC is the publication of the WHO Classification of Tumours (WCT), the knowledge base that underpins cancer diagnosis worldwide. This series of authoritative reference books, also known as the WHO Blue Books [1], is an important resource for pathologists, medical professionals, and cancer researchers globally, providing standards to support diagnosis, treatment, prognostication, and cancer research.
Terminology is the basis for specialist communication and should be used with precision in classifications. The complexity of technical content and of specialist knowledge, as well as the overlapping of specialties and fields, makes it increasingly relevant to pay attention to the accuracy of terminology especially across languages and geopolitical frontiers [2]. Misleading terminology has been recognized as an issue in all fields of technical writing, including the field of healthcare [3,4,5,6,7,8,9,10].
Definitions exist to describe a concept with precision. Three of the most authoritative dictionaries in the world provide similar definitions of the term “definition” as “constituting a precise statement of the essential nature or meaning of something” [11,12,13].
IARC aims to provide clear descriptions of tumors to aid in the correct diagnosis wherever these books are used. Each section describing a tumor begins with a concise definition of precisely what that tumor is before the entity is further delineated under pre-defined headings describing the different aspects that classify a tumor [1]. For patients, this means that their diagnosis is relevant and comparable worldwide and improvements from new research may be applicable for them. For researchers, precise terminologies mean that studies can be reproduced and compared with greater accuracy. Epidemiologists rely on clear definitions to monitor and compare tumors across different countries and registries.
As part of a quality improvement effort, we aimed to assess the extent of usage of potentially misleading terminology in the 5th edition WHO Blue Books, by obtaining and comparing standard definitions for a selection of terms that we considered potentially misleading.
The specific objectives of this project were:
-
1.
To identify a list of potentially misleading terms used in the recently published WHO Blue Books, 5th edition.
-
2.
To search for definitions of the selected terms in common official sources from the pathology and cancer domains.
-
3.
To assess the extent of agreement between the sources.
Methods
Identification of misleading terms
A working group (WG) composed of three senior pathologists from the WCT group (VAW, IAC, MDSL) and a visiting senior pathologist (AO) identified by consensus a list of potentially misleading terms with reasons why they might be considered misleading (Table 1). The potentially misleading terms were divided into eight categories: one prefix, two types of suffixes, eponyms, latinate terms, and the three paired terms of microinvasion/microinvasive, dysplasia/dysplastic, degeneration/degenerative. For the prefixes and suffixes, we did a preliminary search in the two published 5th edition Blue Books [14, 15] to look for the most common words with which these were associated and included these.
Sources of definitions
The WG agreed upon a list of sources to search for definitions of the selected terms. The sources included the WHO web page, the websites of several pathology organizations, medical dictionaries, and representative textbooks. The first reviewer (ZLC) conducted electronic searches for the selected terms in these sources and extracted definitions into a data extraction form (Excel). When searching for definitions, we also searched for slight variations of the words.
Assessment of the agreement of definitions
To evaluate the level of agreement among the retrieved definitions, a three-category ad hoc assessment scale was delineated: (1) agree meant that the definitions were similar and the essential understanding was present in each one; (2) partially agree meant that variations in the definitions were noted and one or more definitions did not convey similar information; and (3) do not agree meant that there was a fundamental difference in definitions.
The two senior pathologists (MDSL, VAW) independently reviewed the definitions and assessed the level of agreement.
Analysis of results
A descriptive analysis was performed, specifying (1) number of sources defining the identified terms; (2) number of times a term was considered “defined,” “described, not defined,” and “not found”; and (3) number of agreements, partial agreements, and disagreements across the sources as assessed by the ad hoc developed scale.
Results
Table 1 lists the 26 terms we identified and the reasons we considered them potentially misleading.
Sources
We identified 16 relevant sources to search for definitions: seven institutions/organizations [16,17,18,19,20,21,22], three dictionaries [11,12,13], four websites [23,24,25,26], and two textbooks [27, 28]. The sources with their summarized definitions of terms are provided in Supplementary material.
We found no definitions for 4/26 (15%) terms: pseudoinvasion, osteoclast-like, serrated dysplasia, and malignant degeneration. Definitions of 3/26 (11.5%) terms, adenoma-like, cystic degeneration, and degenerative nuclear atypia, were only found in one source each and hence, could not be compared. Two of 26 (7.6%) terms, rhabdoid and carcinoid, were defined by the greatest number [10] of sources. Slight variations were noted between sources. In 27 instances, sources used terms and/or provided descriptions but did not specifically define them.
No single source provided definitions for all terms. Two sources [16, 18] had no definitions for any term. Pathology outlines [25] defined the most terms: 16 (61.5%), followed by Dorland’s Medical Dictionary [13]: 14 (53.8%). Generally, organizations defined fewer terms than the dictionaries, websites, and textbooks. From a total of 416 possible definitions (26 terms in 16 sources), we found 111 (26.7%).
Agreement of definitions
Table 2 displays the sources that had definitions or descriptions only and the extent of agreement between these as assessed by two senior pathologists. Of the 26 identified terms, only 19 (73.1%) could be assessed as 7 (26.9%) had none or only one definition.
The reviewers assessed that definitions agreed or partially agreed for 16 (84.2%) of the 19 terms that had two or more definitions (see Table 2). For one term, both reviewers felt that the definitions did not agree. This term was Paget disease (T25) in which not all definitions included both Paget disease of breast and Paget disease of bone, and one definition of Paget disease of breast said that malignant cells invaded the dermis. For two terms, the reviewers could not reach consensus on whether the definitions agreed. These were the terms of carcinoid (T6) and rhabdoid (T8) in which R1 felt that definitions were wrong and did not agree, while R2 felt that they partially agreed.
Discussion
There is little written in the medical literature about the potential for medical terminology to be confusing or misleading. The terminology of a specific subspecialty may be well known to that particular group, but opaque to outsiders and new learners or used differently in other settings. Terminology usage in pathology is no different and many can remember the struggle as medical students to comprehend the plethora of unfamiliar terms. Many in the medical field might also be surprised at the subjectivity of anatomical pathology where diagnosis rests on visual impressions that have interpretive latitude. Terminology usage is also subjective and may be a matter of preference and style. Lack of a consensus and unfamiliarity with a definition are other reasons for questionable usage [7].
A definition is the starting point for clear terminology and the reason why each section of a WHO Blue Book begins with a concise definition of the tumor entity. This is particularly important for a classification that is used internationally, and which needs to consider cultural, idiomatic, and psychological aspects influencing comprehension. We found that concise, easy to understand definitions for pathologic terms were frequently lacking in sources commonly consulted by specialists. Terms were often described or used in the sources, without providing an actual definition. We considered that the finding of only 111 (26.7%) of 416 possible definitions (if all sources had provided definitions for all terms) seems low for a specialized field that underpins the diagnosis and treatment of cancer. However, there is nothing with which to compare this number.
Where present, definitions mainly agreed with each other: for 16 (84.2%) of 19 terms. This level of agreement does not mean that definitions were correct as they probably had not been decided by consensus, but do suggest that if defined, terms are consistently used and variations in definitions are not causes of confusion. However, in one instance, both reviewers agreed that the definitions did not agree with each other, and for two terms, one reviewer felt the definitions did not agree and the second reviewer felt that they only partially agreed. We acknowledge that it is actually difficult to determine the precise cutoff between “partially agree” and “do not agree” but this lack of agreement between the reviewers does indicate a problem with the definitions found in the sources.
We included the informal source Wikipedia [26] and found that it provided more definitions than most of the other consulted sources. However, we do not condone its use because of its lack of oversight and proper editorial review process.
We showed that sources commonly consulted by a wide variety of investigators, many non-native English speakers do not provide definitions for terms that might be used misleadingly. We used textbooks, websites of pathology and cancer organizations, and medical dictionaries in an attempt to cover a wide array of sources that might be consulted by different searchers but did not attempt to be exhaustive. We are particularly concerned about early career professionals, who need access to readily comprehensible definitions to avoid misunderstandings later in their careers.
We are aware that the list of potentially misleading terms was self-selected, but by using a consensus method among the WG, possible biases due to personal experiences were minimized. We focused on commonly used sources that might be consulted by learners or those outside the pathology field to provide a realistic picture of the status of definitions. There may also have been limitations in the searches due to the search engines of the websites.
We realize that judging the level of agreement between definitions is a subjective exercise, but by using a standardized assessment scale that we developed and by performing independent evaluations we sought to diminish bias as much as possible. We did not assess the usage of a particular term in its context since this was beyond the scope of this preliminary work but is considered for future research.
This investigation highlights the need for provision of definitions for terms used in the field of pathology and tumor classification to lessen subjectivity and improve the clarity of pathological diagnoses. This could be done by developing consensus definitions for terminology and a single authoritative source that can be consulted by a wide range of users.
Change history
22 April 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00428-021-03101-w
References
WHO Classification of Tumours Lyon, France: International Agency for Research on Cancer (2020) 5th. Available from: https://tumourclassification.iarc.who.int. Accessed Oct 2020
COTSOES (2002) Recommendations for Terminology Work 2nd, revised and enlarged edition. Editor: Conference of Translation Services of European States Working Party on Terminology and Documentation. Published by: Media Center of the Confederation CH-3003 Berne
Saitz R (2015) Things that work, things that don’t work, and things that matter--including words. J Addict Med 9(6):429–430
Lilienfeld SO, Sauvigné KC, Lynn SJ, Cautin RL, Latzman RD, Waldman ID (2015) Fifty psychological and psychiatric terms to avoid: a list of inaccurate, misleading, misused, ambiguous, and logically confused words and phrases. Front Psychol 6:1100
Meijlink J (2019) Interstitial cystitis/bladder pain syndrome/hypersensitive bladder: worldwide confusion! What has gone wrong and how can we put it right for the sake of the patients? Int J Urol 26(Suppl 1):41–45
Fraser IS, Critchley HO, Munro MG, Broder M (2007) A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril 87(3):466–476
O'Connor CM, Menendez ME, Hughes K, Ring D (2017) Questionable word choice in scientific writing in orthopedic surgery. Arch Bone Jt Surg 5(4):231–234
Ruggeri M, Fortuna S, Rodeghiero F (2008) Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature. Haematologica. 93(1):98–103
Brierley J, O'Sullivan B, Asamura H, Byrd D, Huang SH, Lee A et al (2019) Global Consultation on Cancer Staging: promoting consistent understanding and use. Nat Rev Clin Oncol 16(12):763–771
Yılmaz İ (2018) Confusing terminology: difficult asthma, difficult-to-treat asthma, difficult-to-control asthma, Therapy-Resistant Asthma, Severe Asthma, and Refractory Asthma. Which One is Truly Severe Asthma? Turk Thorac J 19(4):235–236
Oxford English Dictionary (2020) Oxford University Press. Available from: www.oed.com. Accessed Oct 2020
Merriam-Webster Medical Dictioanry (2020) Merriam-Webster Incorporated. Available from: https://www.merriam-webster.com/medical. Accessed Oct 2020
Dorland’s Medical Dictionary Online (2020) Elsevier. Available from: https://www.dorlandsonline.com. Accessed Oct 2020
Breast tumours Lyon, France (2019) International Agency for Research on Cancer. 5th. Available from: https://tumourclassification.iarc.who.int/chapters/32. Accessed Oct 2020
Digestive system tumours Lyon, France (2019) International Agency for Research on Cancer. 5th. Available from: https://tumourclassification.iarc.who.int/chapters/31. Accessed Oct 2020
World Health Organization (2020). Available from: www.who.int. Accessed Oct 2020
International Classification of Diseases 11th Revision Geneva: WHO (2020). Available from: icd.who.int. Accessed Oct 2020
European Society of Pathology: European Society of Pathology (2020). Available from: https://www.esp-pathology.org/. Accessed Oct 2020
College of American Pathologists: College of American Pathologists (2020). Available from: www.cap.org. Accessed Oct 2020
Royal College of Pathologists: Royal College of Pathologists (2020). Available from: www.rcpath.org. Accessed Oct 2020
Royal College of Pathologists of Australasia Royal College of Pathologists of Australasia (2020). Available from: www.rcpa.edu.au. Accessed Oct 2020
International Collaboration on Cancer Reporting: International Collaboration on Cancer Reporting (2020). Available from: www.iccr-cancer.org. Accessed Oct 2020
NIH-National Cancer Institute: National Institutes of Health (2020). Available from: www.cancer.gov. Accessed Oct 2020
Medical Subject Headings (2020) Bethesda MD: U.S. National Library of Medicine. Available from: meshb.nlm.nih.gov/search. Accessed Oct 2020
PathologyOutlines.com Bingham Farms, MI, USA: PathologyOutlines.com, Inc. (2020). Available from: www.pathologyoutlines.com. Accessed Oct 2020
Wikipedia: Wikimedia Foundation, Inc. (2020). Available from: www.wikipedia.org. Accessed Oct 2020
Kumar V et al (2015) Robbins and Cotran pathologic basis of disease, 9th edn. Elsevier/Saunders, Philadelphia
Thun MJ, Linet MS, Cerhan JR, Haiman C, Schottenfeld D (2017) Schottenfeld and Fraumeni cancer epidemiology and prevention, 4th edn. Oxford University Press. https://doi.org/10.1093/oso/9780190238667.001.0001
Author information
Authors and Affiliations
Contributions
VAW, IAC, AO, and BII conceived and designed the study; IAC, VAW, AO, and MDSL provided the expert consensus of the work group; ZLC collected the data; ZLC, BII, and VAW performed the analysis; ZLC, BII, VAW, and MDSL interpreted results; IAC and MDSL resolved disagreements; ZLC, VAW, BII, MDSL, and IAC wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: Retrospective Open Access
Supplementary Information
ESM 1
(DOCX 75 kb)
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific Organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.
About this article
Cite this article
Chow, Z.L., Indave, B.I., Lokuhetty, M.D.S. et al. Misleading terminology in pathology: lack of definitions hampers communication. Virchows Arch 479, 425–430 (2021). https://doi.org/10.1007/s00428-021-03069-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-021-03069-7